Skip to Content

Logo 1934 (Brexin L.A. 8 mg / 120 mg)

Generic Name: chlorpheniramine/pseudoephedrine

Pill with imprint Logo 1934 is Red / Clear, Capsule-shape and has been identified as Brexin L.A. 8 mg / 120 mg. It is supplied by Savage Laboratories.

Brexin LA is used in the treatment of sinusitis; allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Brexin LA 8 mg / 120 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Logo 1934

Brexin L.A.

Generic Name:
chlorpheniramine/pseudoephedrine
Imprint:
Logo 1934
Strength:
8 mg / 120 mg
Color:
Red / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Savage Laboratories
National Drug Code (NDC):
00281-1934

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide